TY - JOUR
T1 - Structure-Based Design of Inhibitors Targeting PrfA, the Master Virulence Regulator of Listeria monocytogenes
AU - Kulén, Martina
AU - Lindgren, Marie
AU - Hansen, Sabine
AU - Cairns, Andrew G.
AU - Grundström, Christin
AU - Begum, Afshan
AU - Van Der Lingen, Ingeborg
AU - Brännström, Kristoffer
AU - Hall, Michael
AU - Sauer, Uwe H.
AU - Johansson, Jörgen
AU - Sauer-Eriksson, A. Elisabeth
AU - Almqvist, Fredrik
PY - 2018/5/10
Y1 - 2018/5/10
N2 - Listeria monocytogenes is a bacterial pathogen that controls much of its virulence through the transcriptional regulator PrfA. In this study, we describe structure-guided design and synthesis of a set of PrfA inhibitors based on ring-fused 2-pyridone heterocycles. Our most effective compound decreased virulence factor expression, reduced bacterial uptake into eukaryotic cells, and improved survival of chicken embryos infected with L. monocytogenes compared to previously identified compounds. Crystal structures identified an intraprotein "tunnel" as the main inhibitor binding site (A I ), where the compounds participate in an extensive hydrophobic network that restricts the protein's ability to form functional DNA-binding helix-turn-helix (HTH) motifs. Our studies also revealed a hitherto unsuspected structural plasticity of the HTH motif. In conclusion, we have designed 2-pyridone analogues that function as site-A I selective PrfA inhibitors with potent antivirulence properties.
AB - Listeria monocytogenes is a bacterial pathogen that controls much of its virulence through the transcriptional regulator PrfA. In this study, we describe structure-guided design and synthesis of a set of PrfA inhibitors based on ring-fused 2-pyridone heterocycles. Our most effective compound decreased virulence factor expression, reduced bacterial uptake into eukaryotic cells, and improved survival of chicken embryos infected with L. monocytogenes compared to previously identified compounds. Crystal structures identified an intraprotein "tunnel" as the main inhibitor binding site (A I ), where the compounds participate in an extensive hydrophobic network that restricts the protein's ability to form functional DNA-binding helix-turn-helix (HTH) motifs. Our studies also revealed a hitherto unsuspected structural plasticity of the HTH motif. In conclusion, we have designed 2-pyridone analogues that function as site-A I selective PrfA inhibitors with potent antivirulence properties.
UR - http://www.scopus.com/inward/record.url?scp=85046422455&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.8b00289
DO - 10.1021/acs.jmedchem.8b00289
M3 - Article
C2 - 29667825
AN - SCOPUS:85046422455
SN - 0022-2623
VL - 61
SP - 4165
EP - 4175
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 9
ER -